Search Results - David Eik

Cytotoxicity of the CD3×CD20 bispecific antibody epcoritamab in CLL is increased by concurrent BTK or BCL-2 targeting by Maissa Mhibik, Erika M. Gaglione, David Eik, John H. Herrick, J. Le, Inhye E. Ahn, Christopher Chiu, Monica Wielgos-Bonvallet, Ida H. Hiemstra, Esther C.W. Breij, Jenny Chen, Edward B. Reilly, Pearlie K. Epling‐Burnette, Edith Szafer-Glusman, Clare Sun, Adrian Wiestner